Exabis Library
Welcome to the e-CCO Library!
P073: Evaluation of DPPH free radical scavenging activity by HPLC technique: a screening method for drugs and nutrients used in inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P073: Let´s talk about sex: an unicentric cross-sectional study on sexual dysfunction, sexual satisfaction and body schema disorders in Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P073: TNF-alpha activity in plasma from patients with inflammatory bowel disease under adalimumab and infliximab treatment evaluated in a cell-based assay
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P074 Histopathologic evaluation and lymphocyte subpopulations of the upper digestive tract of Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0740: Effectiveness and safety of ustekinumab in elderly Crohn's Disease patients
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0741: Adherence to mesalazine suppositories maintenance treatment in patients with ulcerative proctitis: MESUPO multicenter prospective observational study from GETECCU
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0742: Real-world efficacy and safety of Upadacitinib in IBD patients. Preliminary data from the Apulian Network for Inflammatory Bowel Disease (AN-IBD).
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0743: Clinical impact of delayed access to advanced IBD treatment in Latin America. Experience of 8 years from a medium-volume center in Cordobax7x7x7 Argentina.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0744: Observational Real-World Study of Switching from Intravenous to Subcutaneous Vedolizumab in IBD Patients: Clinical and Pharmacokinetic Analysis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0745: Effectiveness of Switching to Subcutaneous Infliximab in Inflammatory Bowel Disease Patients with Inadequate Biochemical Response during Intravenous Administration
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0746: Impact of timing of prophylaxis therapy on post-operative endoscopic recurrence in a real-life cohort of patients whit Crohn’s disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0747: The real-world practice patterns and clinical outcomes of 5-aminosalicylic acid treatment in Korean patients with ulcerative colitis: a population-based retrospective study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0748: Characterisation of Remission Levels in Patients with Ulcerative Colitis Treated with 5-Aminosalicylates: Results of the CARUC-ASA Prospective Multicentre Study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0749: Infection adverse events with tulisokibart over 50 weeks of treatment in the phase 2 Crohn’s disease APOLLO-CD trial
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P074: Association of colonic mucosal infiltration of IgG4 plasma cells with ulcerative colitis activity and presence of primary sclerosing cholangitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P074: Autoimmunity against type IV collagen in ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P074: Crohn’s disease clinical data standards: Adoption and implementation to promote data sharing and reuse.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P074: Decreased levels of circulating protein S (PROS1) in patients with active Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P074: Human amnion epithelial cells reduce intestinal inflammation in a dextran sulfate sodium-induced murine model of acute colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P074: Interferon-γ promotes antigen processing and presentation pathway in the intestinal epithelium of patients with Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM